Φορτώνει......
Equity in HTA: what doesn’t get measured, gets marginalised
When making recommendations about the public funding of new health technologies, policy makers typically pay close attention to quantitative evidence about the comparative effectiveness, cost effectiveness and budget impact of those technologies – what we might call “efficiency” criteria. Less atten...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Isr J Health Policy Res |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BioMed Central
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5502411/ https://ncbi.nlm.nih.gov/pubmed/28694961 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13584-017-0162-3 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|